Siemens DCA™ System Hemoglobin A1c Reagent Kit - HSA Registration DE0016621
Access comprehensive regulatory information for Siemens DCA™ System Hemoglobin A1c Reagent Kit in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0016621 and owned by Siemens Healthcare Diagnostics Inc. The device was registered on December 05, 2014.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Siemens Healthcare Diagnostics DCA HbA1c test can be an aid to diagnose diabetes and identify patients at risk for developing diabetes, monitoring the long-term care of patients with diabetes. This assay provides a convenient, quantitative method for measuring the percent concentration of hemoglobin A1c in blood. The DCA HbA1c assay is for use in laboratories such as physician office laboratories, clinics, and hospitals.